Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Win-Win: Safer Laparoscopic Surgery in Less Time

Win-Win: Safer Laparoscopic Surgery in LessTime

ClickClean instantly cleans the scope without removing from the abdomen, so the surgeonโ€™s view stays sharp and clear. No more frustrating, repeated delays for scope removal, cleaning, and reinsertion in the OR.

Scope cleaning has always been a major frustration for laparoscopic surgeons. We put all of our focus on performing surgery, and weโ€™re repeatedly interrupted by the need to clean the lens.

The situation looks like this: Surgery is underway. We have a perfect view. Weโ€™re retracting something very nicely. If itโ€™s a difficult procedure, we might think, โ€œThis has been tough, but now Iโ€™m making progress.โ€ Suddenly, we canโ€™t see. The scope has fluid, smoke, or grease on it. We stop what weโ€™re doing and let go of the tissue weโ€™ve been retracting. We pull out the scope, clean it, and reinsert it to the same location. Sometimes we still canโ€™t see clearly, so we take it out and clean it again. Then we try to pick up where we left off a few minutes earlier. Sometimes itโ€™s hard to get the same perfect angle we had before. We think, โ€œI just had it!โ€ but it takes another 10 minutes to get it just right and resume surgery.

This happens over and over throughout surgery โ€“ in some cases, every 3 to 4 minutes. Struggling with visualization makes the case 10 times more difficult. Nothing about surgery frustrates and fatigues me more. More importantly, operating through a cloudy lens is as unsafe as a surgeon wearing dirty glasses. And everything that prolongs surgery and anesthesia use increases risk, especially for patients with other health problems.

When a surgery rep told me about ClickClean, which would allow me to click a button to clean the scope without removing it at all, I said, โ€œI’m already interested.โ€ After trying it a few times, I told him, โ€œI want this โ€“ that’s all there is to it.”

A Safer, Faster Way
ClickClean is a clear microfilm sheath that covers the laparoscopeโ€™s tip, including the lens. As blood, smoke and debris hurt visibility, the surgeon clicks the device, advancing the film so a clean length covers the lens. We instantly get an unobscured view. We can see clearly and work safely throughout the entire case. The ClickClean device fits standard 10mm scopes; a 5mm version is in development. And itโ€™s very easy to use โ€“ just clicking a button.

The OR time we save can be significant. Ten 3-minute cleanings add 30 minutes to surgery, and now thatโ€™s erased.

Most importantly, surgery is safer and better for our patients. With better visualization, dissection is safer, easier, and faster, with less risk of injuring surrounding structures. Because surgeons can focus solely on the procedure without interruptions, we can always work to the best of our abilities.

Shaving time off of surgery is an enormous benefit in acute cases, where speed is key. If my patient has an acute gallbladder infection or perforated appendicitis, I need to remove the organ as quickly as possible. In all cases, itโ€™s good to reduce the time patients spend under anesthesia, but that is especially important when patients are elderly or obese or have respiratory problems, diabetes, heart disease, or other health problems.

When I laid out these safety advantages, the potential for better outcomes, and the efficiency of ClickClean, it was an easy decision for me and for my administrator. Weโ€™ve eliminated perhaps the biggest frustration for any laparoscopic surgeon and saved ourselves some OR time, all while doing better for our patients.

UK Digital Healthtech companies to showcase ground-breaking technologies at MEDICA 2019

UK Digital Healthtech

The worldโ€™s first โ€˜smartโ€™ peak flow meter that connects to a smartphone and a software platform that turns exercise into video games are two of the cutting-edge technologies that will be showcased alongside a range of pioneering UK digital health innovations at MEDICA 2019.

This year, the ABHI UK Pavilion โ€“ organised by theย Association of British HealthTech Industries โ€“ will highlight a range of ground-breaking UK digital health technologies, giving an international platform to the digital transformation breathing new life into the medical world.

Exhibitors include MIRA Rehab, whose medical software turns physical and cognitive exercise into video games. Using motion tracking sensors, MIRA (Medical Interactive Recovery Assistant) is designed to make physical therapy easier and more fun for patients while helping clinicians track their patients’ progress through means of telerehabilitation. By โ€˜gamifyingโ€™ exercise, the device is helping to change the way physical therapy is delivered, which can be a long and arduous process for those in need of rehabilitation.

Another revolutionary new device being showcased on the ABHI UK pavilion is the worldโ€™s first โ€˜smartโ€™ peak flow meter that connects to a smartphone. Utilising smartphone sensor technology, the device can predict a potential attack up to 7 days in advance, allowing asthma patients to better manage their condition. The smart device, created by Smart Respiratory Products, allows patients to understand their peak flow (the measure of how quickly you can blow air out of your lungs) through a mobile app and is set to aid the 235 million asthma sufferers worldwide.

Paul Benton, Managing Director, International, said: โ€œThe medical industry is driven by innovation, and digitalisation has allowed the medical world in Britain to take great strides into the future. We are excited to be able to showcase and give an international platform to these ground-breaking technologies on our UK Pavilion at MEDICA.โ€

Digital health forms part of one of the fastest growing economic sectors in the world. The UK digital health market was valued at $4 billion in 2017 โ€“ and is forecasted to reach $28.3 billion by 2025. Globally, the digital health market is set to exceed $379 billion by 2024.

Digital health will be featured prominently at this yearโ€™s MEDICA. ABHI will again be leading the UKโ€™s largest and most visible Pavilion of health technology companies at the show, which takes place from 18 โ€“ 21 November 2019.

About ABHI

ABHI is the UKโ€™s leading industry association for health technology (HealthTech).

ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UKโ€™s economic growth. HealthTech is now the largest employer in the broader Life Sciences sector, employing 127,400 people in 3,860 companies, with a combined turnover of ยฃ24bn. The industry has enjoyed growth of around 5% in recent years. ABHIโ€™s 300 members account for approximately 80% of the sector by value.

Highlights of the 9th edition Medical Fair Thailand 2019

PrinterPrezz and Osseus Partner to Develop Family of 3D Printed Spine Implants

PrinterPrezz and Osseus Partner to Develop Family of 3D Printed Spine Implants

PrinterPrezz Inc., a trailblazer in combining metal 3D printing, nanotechnologies and surgical expertise to design and manufacture next generation medical devices announced an agreement to work together on new spinal interbody fusion devices with Osseus Fusion Systems, a Dallas-based medical device company focused on spine products.

The two companies have been collaborating since late 2018 to develop the next generation Aries series of products, including ALIF, cervical and expandable lumbar fusion cage designs. The companies plan to submit applications for multiple new devices to the U.S. Food and Drug Administration (FDA) in late 2019.

Dr. Alan Dang, chief medical officer of PrinterPrezz and board-certified orthopaedic spine surgeon, commented, โ€œTogether, Osseus and PrinterPrezz are focused on leveraging the latest in additive manufacturing technologies to create advancements in spinal interbody fusion devices. A combination of biocompatible materials, innovative design and the latest in metal 3D print technology enables clinicians and engineers to jointly develop porous titanium implants with advanced geometries and lattices that optimize surgeon ergonomics to shorten procedure time and minimize soft tissue injury.โ€

Eric Hansen, CEO of Osseus, added, โ€œThe next generation of our Aries interbody fusion devices will feature optimized lattices to encourage bone on- and through- growth, as well as optimized micro-structure topography designed to facilitate fusion. Working with the expert team at PrinterPrezz allows our designers access to an advanced facility with a streamlined design and manufacturing flow, which enables us to keep up with the rapid pace of R&D innovation and quickly grow our product portfolio to meet the needs of our physician customers. The ability to prototype designs utilizing different 3D printer technologies at PrinterPrezz is an additional benefit as we experiment with new structures and lattices.โ€

Shri Shetty, CEO of PrinterPrezz, said, โ€œCompanies like Osseus are the innovators in the spine market and are part of the group that represents approximately half the market of next generation device submissions. Research and development costs, timelines and filing complexity are the biggest challenges for midsize innovators. By partnering with such companies, PrinterPrezz can help to reduce the time and cost associated with developing new products and facilitate both efficient and timely 510(k) applications. We look forward to designing and manufacturing future spine surgery innovations through our partnership with Osseus.โ€

The PrinterPrezz model allows customers to leverage expertise in engineering, medical consulting, infrastructure and development to bring meaningful innovations to market more quickly. New medical devices that result from the collaboration between Osseus and PrinterPrezz are expected to yield innovations that are designed to leverage the latest in additive manufacturing technologies and to be built at PrinterPrezzโ€™s San Francisco Bay Area Innovation Center.

About Osseus
Osseus was founded in 2012, and is based in Dallas, Texas. Osseus is an innovative medical device firm focused on developing advanced technology products for minimally invasive surgery. Its team of visionary product developers and forward-thinking surgeons push the boundaries of device development, creating unique products that make surgeries more successful, help patients recover faster, and improve healthcare outcomes. The Osseus product line includes Black Diamond Pedicle Screw System, White Pearl Anterior Cervical Plate, Red Ruby Anchored Cervical Interbody, Gemini-C Cervical Interbody and now Aries-TS, Aries-TC, Aries-A, Aries-L, and Aries-O. For more information about Osseus, please visit www.osseus.com.

About PrinterPrezz
PrinterPrezzโ€™s mission is to bring more ideas for innovative medical devices to market faster, connecting medicine and manufacturing to become the first Medifacturingโ„ข company in the world. By developing advanced medical devices using processes that combine expertise in 3D printing, orthopaedics, semiconductor and nanotechnologies, PrinterPrezzโ€™s ultimate goal is to provide medical solutions that enable people to enjoy active lives longer. PrinterPrezzโ€™s ecosystem aims to solve challenges for various parts of the medical innovation value chain by providing prototyping, development, and manufacturing services to create life-enhancing medical devices. PrinterPrezz provides customers with access to a variety of 3D printing machines, 3D manipulation software, and 3D scanners as well as advanced manufacturing processes, and surgeon education programs. Medical solutions created by PrinterPrezz are designed to enable more people to live happier and more gratifying lives. For additional information about the company, please visit www.printerprezz.com.

Mobile Heartbeat Collaborates With Eisenhower Health to Improve Emergency Response Communication

Improve Emergency Response Communication

Healthcare communications company Mobile Heartbeatยฎ has announced a collaborative partnership with Magnet Recognized Eisenhower Health of Rancho Mirage, California. The aim of the partnership has been to develop a more comprehensive communication network, specifically tailored to emergency and disaster response situations. The collaboration comes following an active shooter incident on the Eisenhower Health campus back in March of 2019.

After the incident, Mobile Heartbeatโ€™s Clinical Optimization Team compiled a report containing communication data analytics from the units that were affected. Working with Eisenhowerโ€™s Annette Brown, Chief Nursing Informatics Officer, and Tim Beringer, Director, Employee Health and Safety, Security and Emergency Management, the Mobile Heartbeat team provided recommendations for improving the existing processes and communication structure.

Suggested improvements included an enterprise-scale rollout of MH-CURE, which will allow Eisenhowerโ€™s security team to send more timely hospital-wide updates instantaneously; ad-hoc contact groups and dynamical roles that will allow for quicker and easier deployment of the incident command center; and a stronger emphasis on bi-directional communication across the entire continuum, which will allow staff at the point of care to communicate critically important information with leadership.

โ€œHospitals need to understand that communication is critical to inform all employees, all patients, everyone about what is happening during a critical situation,โ€ said Ann Mostofi, Vice President, Patient Care Services and Chief Nursing Officer, Eisenhower Health. โ€œWe have found that Mobile Heartbeat can be that source of inside โ€˜truth,โ€™ with almost instantaneous communication about what is reallyย happening.โ€

 

As these recommendations are implemented across Eisenhowerโ€™s campus, the Emergency Management Team is optimistic that MH-CURE will help them support the safety and security of staff, patients and visitors in the event of an emergency orย disaster.

โ€œItโ€™s been really great working with the Mobile Heartbeat team,โ€ Beringer said. โ€œI have a lot more confidence that our leaders are comfortable in the role of incident commander, and they would be able to initiate our hospital incident command and communicate with our staffย appropriately.โ€

About Eisenhower Health

Eisenhower Health is a not-for-profit, comprehensive health care institution that includes the 463-bed Eisenhower Hospital, the Barbara Sinatra Childrenโ€™s Center at Eisenhower and the Annenberg Center for Health Sciences at Eisenhower. The Betty Ford Center is also located on the Eisenhower campus. Eisenhower is renowned for its Centers of Excellence in Orthopedics, Cardiovascular, Neuroscience and Oncology. Situated on 130 acres in Rancho Mirage, and with outpatient clinics across the valley, Eisenhower Health has provided a full range of quality medical and educational services for more than 45 years for residents and visitors to the greater Coachella Valley. Eisenhower has earned ANCC Magnet Recognitionยฎ for professionalism in nursing and excellence in patient care. The first accredited teaching hospital in the valley, Eisenhower trains physician residents in both Internal Medicine and Family Medicine. For more information, visit EisenhowerHealth.org

Sysmex America and LabCorp Extend Hematology Automation Agreement with Sysmex XN-Series Technology

Sysmex XN-Series Technology

Sysmex America, Inc. and LabCorp announced an extension of their hematology automation agreement, to provide LabCorp Diagnosticsโ€™ primary reference laboratories with Sysmex Americaโ€™s latest, upgraded XN-Series technology. The new XN-9100 system is a scalable, modular automation system that incorporates sample sorting robotics from Yaskawa Motoman. The system reduces turnaround time and optimizes labor utilization while maintaining high-quality patient results, with a smaller footprint that frees up laboratory space to be used for other operational needs.

Since 2006, when Sysmex America and LabCorp entered into their first hematology instrument agreement, LabCorp has increased test volumes by approximately 50 percent while using less laboratory space. Moving forward, LabCorp expects to see similar improvements in performance as it deploys the XN-9100 system across its laboratory network. The system has been implemented and successfully integrated into LabCorpโ€™s workflows in its Atlantic Division regional laboratory in Burlington, N.C., and the company plans to install it in 11 additional LabCorp regional laboratories across the country by early 2021.

โ€œCollaborative relationships, like this one with LabCorp, and continuous customer feedback are key to Sysmex Americaโ€™s ability to respond to both current and future challenges of clinical labs,โ€ said Andy Hay, chief operating officer of Sysmex America. โ€œOur long-term partnership and learnings have allowed us to support LabCorpโ€™s growth since we first began working together in 2006. The update to the XN-9100 will help to accommodate LabCorpโ€™s planned growth for the next ten years.โ€

โ€œThe laboratoryโ€™s central role in providing better healthcare is always evolving, and Sysmex Americaโ€™s innovative solutions help LabCorp fulfill its mission to improve health and improve lives through world-class diagnostics,โ€ said Mark Schroeder, LabCorpโ€™s chief global supply chain officer. โ€œLabCorpโ€™s close collaborations with Sysmex and other supply chain partners are improving the delivery of patient care.โ€

The collaboration between Sysmex America, LabCorp and Yaskawa Motoman has helped spur the design of compact and efficient hematology work cells that are an integral part of the XN-9100 system. Each fully self-contained work cell includes automatic hopper fed sample loading, full hematology analysis with automated reflex and repeat testing as needed, onboard slide making, staining, digital morphological analysis and post-analytic sorting and archiving.

Sysmex Americaโ€™s XN-9100 enables labs of all sizes, complexity and specialty to meet their needs. To learn more about Sysmex hematology products visit www.sysmex.com/us.

?About Sysmex America, Inc.
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit www.sysmex.com/us.

About LabCorp
LabCorp , an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster, and uses technology to improve the delivery of care. LabCorp reported revenue of more than $11 billion in 2018. To learn more about LabCorp, visit www.LabCorp.com, and to learn more about Covance Drug Development, visit www.Covance.com.

About Yaskawa Motoman
Founded in 1989, the Motoman Robotics Division of Yaskawa America, Inc. is a leading robotics company. With over 450,000 Motomanยฎ robots installed globally, Yaskawa provides automation products and solutions for virtually every industry and robotic application; including arc welding, assembly, coating, dispensing, material handling, packaging, palletizing and spot welding. Similarly, Yaskawa Motoman is unique in serving the ultra-high throughput clinical laboratory with automated solutions for pre- and post-analytic specimen processing, as well as fully-connected, end-to-end processing solutions.

Guerbet and IBM Watson Health announce a second co-development project as part of their strategic partnership for leveraging artificial intelligence in medical imaging

 leveraging artificial intelligence in medical imaging

Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, announced that it has signed a new agreement with IBM Watson Health to co-develop and co-commercialize an artificial intelligence (AI) solution to help clinicians diagnose and monitor patientswith prostate cancer. This agreement follows the firstagreementsigned in July 2018 between the two companies with the aim of using an artificial intelligence program to help clinicians diagnose and monitorpatients with liver cancer.

Under this second program, Guerbet and IBM will work to develop a tool using artificial intelligence with the goal of helping to detect, segment, characterize and monitor lesions over time. This AI approach mayallow for faster and more informed diagnosis of prostate cancer.Prostate cancer is the second most commonly diagnosed cancer in men (13.5% of male cancer diagnoses worldwide according to the WHO). iThe number of prostate MRIs is currently increasing by more than 10% per year, and a 2017 Lancet clinical studyiihas shown that 27% of biopsies may be avoided and 18% of unseen cancers detected by using multiparameter MRI.

โ€œThe main diagnostic challenge with prostate cancer lies inidentifying cancers requiring rapid treatment and those requiring only active surveillance, while avoiding unnecessary biopsies,iiisaid David Gruen,M.D., Chief Medical Officer, Imaging, IBM Watson Health. โ€œFor this reason, optimal patient outcomes depend on the rapid and accurate diagnosis and treatments that AI technologies can potentially help provide.”โ€œThe aging of our population has made prostate cancer a global public health problem. Some prostate cancers warrant active therapeutic management while others require only regular monitoring. Augmented intelligence can help enable doctors to diagnose these different cases more rapidly and more accurately, thus helping to potentially reduce the number of unnecessary biopsies and allowing them to propose the most appropriate therapeutic strategy for each patient.

We look forward to strengthening our collaboration with IBM Watson Health to expand our portfolio of innovative diagnostic and surveillance solutions in oncology,โ€ said Yves Lโ€™Epine, CEO of Guerbet.The AI solutionfor prostate will be designed for compatibility with most PACS (Picture Archiving and Communication System) visualization systems, which will make its direct integration into the workflows of healthcare professionals that much easier. โ€œWe are excited to further strengthen our partnership with Guerbet that has already been active in liver cancerโ€, said Anne LeGrand, General Manager Imaging, Life Sciences & Oncology, IBM Watson Health.

โ€œThis AI solution for prostatewill be one in a range of decision support solutions using Watson image analysis, that maypotentially help radiologists and oncologists to diagnose conditions and make clinical decisions with patients.โ€

2โ€œWith IBM Watson Health, we will be leveraging progress made under the initial liver collaboration for the purposes of this second project dedicated to prostate cancer, with the same aim of delivering augmented intelligence to help radiologists and oncologists. This partnership is in line with Guerbetโ€™s commitment to developing ambitious medical solutions to speed up diagnosis, improve the patient experience, and reduce clinical risks and costs,โ€ said Franรงois Nicolas, Chief Digital Officer for Guerbet

About Guerbet
Guerbet is a pioneer in the contrast-agent field, with more than 90 yearsโ€™ experience, and is a leader in medical imaging worldwide. It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation. Guerbet (GBT) is listed on Euronext Paris (segment B โ€“mid caps) and generated โ‚ฌ790million in revenue in 2018. For more information about Guerbet, please visit www.guerbet.com.About IBM Watson HealthWatson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health. Watson Health technologies are tackling a wide range of the worldโ€™s biggest healthcare challenges including cancer, diabetes, drug discovery and more.

IHFโ€™s agenda for the 43rd World Hospital Congress rallies for people-centered health services in times of peace and crisis

IHFโ€™s agenda for the 43rd World Hospital Congress rallies for people-centered health services in times of peace and crisis

Hosted by the Ministry of Health of the Sultanate of Oman, the 43rd World Hospital Congress of the International Hospital Federation (IHF) will go over some of the most pressing subjects in the global healthcare community in over 40 sessions lined up for discussion on 6 to 9 November in Muscat.

In between times of peace, situations of humanitarian crisis always manage to creep in or sweep off the guards of healthcare systems and even governments. Epidemics, wars and terrorist attacks, natural disasters and man-made hazards, and major cases of poverty and famine often fall on the ground wrecking communitiesโ€™ health defenses. The persistence of these phenomena and their prevailing nature demand collective attention and actionable long-lasting mitigation plans, which are best formulated with resilient health services, health investments for prosperity, and innovations for health impact.

Under an overarching theme โ€œPeople at the heart of health services in peace and crisisโ€, the agenda of the World Hospital Congress will cover the stages of preparation while in peace, action when in crisis and moving forward to better healthcare services for communities.

The World Health Organization (WHO) will be hosting an opening keynote session on the role of hospitals in support of universal health coverage to be presented by Dr. Edward Kelley, Director of the Department of Integrated Health Services of WHO. It will be followed by a ministerial-level panel discussion to further explore how hospitals are integral to the UHC and PHC agenda and how they can contribute to transforming health systems.

In another keynote presentation, Dr. Akihiro Seita, Director of Health Programme of UNRWA (UN Relief and Works Agency for Palestine refugees in the Near East) will share about the challenge of UNRWA in providing Palestine refugees access to hospital services. In succeeding sessions, stories and perspectives taken right from the terrorist attacks in Kenya and the continuing displacement and refugee casualties in Afghanistan are ready to open many eyes to the bigger fights of the healthcare community against massive violence.

A number of sessions are equally dedicated to reviewing the central role of hospitals in the health system. In a keynote session, Dr. Agnes Soucat, Director of Health Systems Governance and Financing at WHO will help delegates further understand the role of hospitals and health services affecting population well-being. Likewise, Dr. Melinda Estes, President and Chief Executive Officer of the Saint Lukeโ€™s Health System in USA will share her knowledge about how hospitals and health systems can drive community health and prosperity.

Inspiring accounts about the birth of the Oman Cancer Association, an Omani community built from the sentiments of a cancer survivor now collaborating with several programs supportive of cancer patients, will also be told by Hon. Yuthar Mohammed Al Rawahy, Founder and Honorary Life President of the Oman Cancer Association. More sessions from this yearโ€™s congress host โ€“ the Ministry of Health of the Sultanate of Oman โ€“ will share about Omanโ€™s stories of resilience, the integrated healthcare system they have established, as well as e-health innovations and achievements.

Innovation pathways will also take the floor in a keynote presentation to be delivered by Sir Andrew Dillon CBE, Chief Executive of the National Institute for Health and Care Excellence in UK. More topics on health innovations will be tackled in detail through the inspiring digital transformation experience of Catalonia and the huge success of Taiwanโ€™s healthcare IT transformation.

GS1 Healthcare has also arranged a session to share examples from several countries of enhanced healthcare results by the introduction of global standards, starting at procurement in healthcare organizations.

The concept of โ€˜anchor institutionsโ€™ will be elaborated by senior health service leaders and experts from the NHS Confederation.

Composed of several more currently relevant topics, the agenda of the Congress will once again serve eye-opener stories happening around the globe posting both serious challenges and ripe potentials to innovate and invest on people-centered health services whether in peace or in crisis.

The IHF Muscat World Hospital Congress will take place through four consecutive days of knowledge harvest including pre-Congress sessions on โ€˜Economics for Healthcare Leadersโ€™ and โ€˜The โ€œFast Forwardโ€ Initiative for community- and person-centered hospitals and health servicesโ€™. This annual event will close with a hospital tour to The Royal Hospital and the Sultan Qaboos University Hospital. Visit the Congress website to view the entire agenda and the list of speakers: https://worldhospitalcongress.org/

About World Hospital Congress
The World Hospital Congress of the International Hospital Federation (IHF) is a unique global forum that brings together leaders of national and international hospital and healthcare organizations to discuss key drivers of national and international policy, management, financial trends and solutions in healthcare management and service delivery. Through this forum multidisciplinary exchange of knowledge, expertise and experiences are facilitated, together with dialogue on best practices in leadership in hospital and healthcare management and delivery of services. The IHF World Hospital Congress is a one-stop shop for the healthcare professional seeking the opportunity and environment in which to engage in a 360-degree learning and knowledge-sharing experience among peers.

About the International Hospital Federation (IHF) Established in 1929, the IHF is an international not for profit, non-governmental membership organization. Its members are worldwide hospitals and healthcare organizations having a distinct relationship with the provision of healthcare. The IHF provides its members with a platform for the exchange of knowledge and strategic experience as well as opportunities for international collaborations with different actors in the health sector. IHF recognizes the essential role of hospitals and health care organizations in providing health care, supporting health services and offering education. Its role is to help international hospitals work towards improving the level of the services they deliver to the population with the primary goal of improving the health of society. www.ihf-fih.org

MEDICAL FAIR THAILAND breaks multiple attendance and participation records at its 9th edition

MEDICAL FAIR THAILAND breaks multiple attendance and participation records at its 9th edition

MEDICAL FAIR THAILAND 2019 proved to be a roaring success as it welcomed more than 11,525 trade visitors from over 70 countries and regions, and 900 exhibitors and 21 national and group pavilions; breaking records and exceeding expectations on multiple levels when it closed last week. The 28 percent increase in visitors from the 2017 edition as well as the exhibitionโ€™s growing international profile saw nearly 40 percent of visitors coming from outside Thailand.

The marked increase in visitorship from the neighbouring markets of Cambodia, Myanmar and Vietnam, is also testament to the regionโ€™s demand, and readiness, to procure medical solutions and healthcare innovations at trade platforms such as MEDICAL FAIR THAILAND. The 3-day exhibition also hosted several visiting delegations and various industry trade associations from all over the world โ€” another strong indication of MEDICAL FAIR THAILANDโ€™s standing as a must-visit sourcing platform.

MEDICAL FAIR THAILAND 2019

The success story of first-time Korean exhibitor, Plasmapp Co. Ltd underlines MEDICAL FAIR THAILAND as the ideal business event for meeting targeted and quality trade visitors in the medical and healthcare sector; on the second day of the exhibition, Plasmapp Co. Ltd secured a US$2 million contract โ€“ their company specialises in medical sterilisation devices which utilises high-quality plasma solutions. According to its CEO, Mr Youbong Lim; โ€œWe have participated in many exhibitions and MEDICAL FAIR THAILAND has been really good as we are able to meet genuine dealers here. We have met potential leads from many countries, including Thailand and Singapore and we are overall very impressed with the exhibition.โ€

MEDICAL FAIR THAILAND began in 2003 with just 177 exhibitors but has grown exponentially over the last 16 yearsas it continues to reinvent itself with its forward-looking approach. This yearโ€™s edition profiled two new innovative featuresโ€” the Community Care Pavilion which focuses on products and solutions for an ageing population such as remote sensors and monitoring devices and mobility solutions; as well as the Start-Up Parkโ€”a platform for start-ups to showcase their innovations and to meet potential investors and customers.

A hit with visitors and other exhibitors on the show floor, who were impressed by the range of technology on display, the Start-up Park showcased companies from Singapore, Japan, South Korea, Hong Kong, Taiwan and Thailand.According to Dr. Subhasis Banerji, Founder and Managing Director of SynPhNe Pte Ltd, of one of the Start-up Park exhibitors, โ€œWe had a good stream of potential customers from local hospitals as well as visitors from India whom we had good conversations with.โ€SynPhNe is a Singapore-based start-up specialising in wearable technology and solutions, and therapy devices that help restore coordination and mobility for those who have suffered brain injury or stroke.

On the local front, the positive visitor numbers can also be attributed to the surge in the number of hospital and group visits from various public and private hospitals, medical facilities, and related establishments from Bangkok and the surrounding provinces. Bangkok Hospital, King Chulalongkorn Memorial Hospital, Ramkhamheang Hospital, and Vejthani Hospital were among the 95 organisations who sent groups of representatives to MEDICAL FAIR THAILAND 2019.

The heightened interest from the local medical and healthcare community in promoting Thailandโ€™s expertise and capabilities was further reflected on the show floor under the umbrella of three Thai pavilion organisers; Thailand Center of Excellence of Life Sciences (TCELS), the Medical and Health Device Manufacturers Industry Club (MEDIC), and long-time exhibitor National Innovation Agency (NIA) of Thailand. This was NIAโ€™s fifth time exhibiting at MEDICAL FAIR THAILAND and MEDICAL FAIRASIA; which takes place in Singapore.The 60-strong representation from Thai companies was also indicative of the countryโ€™s commitment to further strengthen its position as a leading hub for pharmaceuticals and medical devices, and a world-class provider of medical care under the Thailand 4.0 initiative.

The next edition of MEDICAL FAIR ASIA will be held from 9 to 11 September 2020 at Marina Bay Sands, Singapore. A detailed post event report on MEDICAL FAIR THAILAND 2019 will be released soon.

Siemens Healthineers agrees to acquire majority stake in leading U.S. healthcare consultancy firm

Siemens Healthineers agrees to acquire majority stake in leading U.S. healthcare consultancy firm

In a move to expand its Enterprise Services business, Siemens Healthineers AG, through Siemens Medical Solutions USA, Inc., has signed an agreement to acquire a majority stake in ECG Management Consultants, a leading U.S. healthcare advisory firm. The company, with its principal office in San Diego, California, maintains 10 offices throughout the United States and has a sole focus on the healthcare sector.

โ€œThe advisory business of ECG is a strong addition to our portfolio and a further step in the implementation of our strategy 2025. In combination with our strong medical technology portfolio including our digital platforms and solutions, the partnership with ECG will enable us to address the needs of our customers more comprehensively than ever before, helping them to further improve healthcare delivery and provide better care at lower costโ€, said Bernd Montag, CEO of Siemens Healthineers AG.

โ€œThe partnership with Siemens Healthineers is a unique opportunity for ECG Management Consultants to further grow our business. We will be able to build on the deep clinical and medical knowledge of Siemens Healthineers, its digital platforms, its customer relationships and its global network. We are excited about the joint opportunities for long-term business Value Partnerships. The partnership with Siemens Healthineers will put ECG in an even better position to continue serving our clients as a trusted advisor and helping them remain successful in a changing healthcare environmentโ€, said Gary Edmiston, CEO of ECG.

Reference number: PR-20190910036SHS Page 2/4 ECG will continue as a partnership and will operate as a stand-alone unit with independent customer access. The current CEO, Gary Edmiston, and management team will continue to lead the business. The transaction is expected to close in the first quarter of fiscal year 2020, subject to receipt of regulatory approvals. ECG will be part of the global Enterprise Services business of Siemens Healthineers. The acquisition is a further step in the implementation of the โ€œSiemens Healthineers Strategy 2025โ€ as it addresses the goal to tap into adjacent growth markets.

With around 300 employees, thereof more than 200 consultants, ECG generated sales of more than $100 million in 2018 and is highly profitable. Founded in 1973, ECG has developed a strong portfolio of management consulting services in the areas of strategy, finance, operations and technology. ECG serves many of the leading hospitals, health systems, academic medical centers, childrenโ€™s hospitals, ambulatory surgery centers and healthcare payers in the U.S. ECGโ€™s highly specialized expertise and strong focus on client service has enabled the company to deliver smart counsel and pragmatic solutions to the critical challenges healthcare providers are facing.

โ€œThe outstanding consulting capabilities of ECG, along with our well established customer Value Partnership approach, will enable us to serve hospitals and health systems on a much more comprehensive level, deepen our customer relationships in the long term, and open up a new dimension of growth opportunitiesโ€, said Joรฃo Seabra, Head of Enterprise Services at Siemens Healthineers.

The Enterprise Services business of Siemens Healthineers has a strong track record in delivering on long-term business Value Partnerships. By combining technology leadership with profound experience in clinical consulting and workflow optimization, Siemens Healthineers is creating value beyond its product and service business for healthcare institutions. With ECG ‘s wide-ranging expertise in strategic and transformational consulting services, Siemens Healthineers can take its customer Value Partnerships to the next level โ€“ to help customers evolve in a changing environment. At the same time, these long-term partnerships combined with the global network of Siemens Healthineers will provide substantial growth opportunity for ECGโ€™s core business in healthcare consulting.

Translate ยป